Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

The foreword introduces a medical issue discussing male hormonal health, treatments, and the effects of conditions like obesity and aging.

The guideline recommends mental health involvement in diagnosing gender identity disorder and outlines hormone and surgical treatment protocols, emphasizing safety, informed consent, and long-term monitoring.

Finasteride effectively treats baldness but may cause sexual side effects.

Integrating best practices for steroid users in Swiss primary care is feasible and beneficial, but doping laws need change.

Men with thinner hair from genetic hair loss may be more likely to have an enlarged prostate.

Androgen Deprivation Therapy for prostate cancer often reduces sexual function but intermittent therapy may be more tolerable.

Finasteride doesn't harm male fertility or sperm quality, but may slightly reduce ejaculate volume.

Gynecologists should provide comprehensive care for transgender patients, including mental health evaluation, hormone therapy, and surgical options, while monitoring for side effects and ensuring patient safety.

Androgen receptors are key for development and health, affecting conditions like prostate cancer and male pattern baldness.

Finasteride effectively treats male pattern baldness, improving hair growth and density.

Steroid sex hormones activate matriptase in prostate cancer cells but not in breast cancer cells.

Testosterone boosts red blood cell production and changes iron metabolism without needing dihydrotestosterone.

Selective non-steroidal inhibitors of 5α-reductase type 1 can help treat DHT-related disorders.

Blocking DHT production more strongly may help control advanced prostate cancer and improve quality of life.

New treatments for hair loss show promise, especially finasteride for men and a stronger minoxidil formula.

New pregnane derivatives are effective at inhibiting an enzyme linked to hair loss and reducing oil gland activity.

Sex neurosteroids cause different effects on hippocampal synaptic plasticity in males and females.

More adolescent girls in urban areas of India have Polycystic Ovary Syndrome compared to those in rural areas.

Certain inhibitors can potentially treat prostate cancer and other hormone-dependent conditions by controlling sex hormone levels in cells.

Hormones and genetics play key roles in male and female baldness, which can affect mental health and may be linked to other health issues.

Selective Androgen Receptor Modulators (SARMs) are drugs that can control the effects of androgens in different tissues, potentially having fewer side effects and promising for treating various conditions.

The document concludes that non-operative treatment for gender dysphoria is safe and effective, and hormone therapy does not increase cancer risk.

DHT is a strong androgen that may pose less risk to the prostate compared to testosterone.

Dihydrotestosterone treatment can help penis growth in boys with 5α-reductase deficiency but doesn't fully normalize size after puberty.

Smaller substituents at C-17 enhance the inhibitory activity of progesterone derivatives on 5alpha-reductase.

Saw palmetto extract can block the enzyme that converts testosterone in pig prostate cells.

New treatments for prostate cancer and BPH show promise, including novel compounds that target hormone synthesis and response.

Medications for enlarged prostate can cause sexual side effects like reduced libido, erectile dysfunction, and ejaculatory problems.

The document concludes that hormone therapy is essential for treating gender dysphoria, with specific drugs and monitoring protocols recommended for safety and effectiveness.

Berberine may reduce prostate enlargement by blocking inflammation.